<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-65747</identifier>
<setSpec>0004-2927</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:description xml:lang="en">Crude extracts and a fatty acid, octadec-7-en-5-ynoic acid (1), from the root bark of Capparis zeylanica Linn. (Fam. Capparidaceae) were screened for their antibacterial activities against Gram positive and Gram negative bacteria. Among the crude extracts, chloroform extract showed good activity against all test organisms. The fatty acid (1) isolated from chloroform extract exhibited antibacterial activities against test organisms except E. coli. The activities were compared to a standard antibiotic- kanamycin. The minimum inhibitory concentrations (MICs) of 1, determined byserial dilution technique, were found to be 64 mg/ml against Bacillus subtilis and Shigella dysenteriae. The cytotoxic activities of crude extract and fatty acid (1) were observed by brine shrimp biassay and LC50 value of the compound was found to be 6.27 mg/ml (AU)</dc:description>
<dc:creator>Haque, M</dc:creator>
<dc:creator>Haque, ME</dc:creator>
<dc:creator>Rahman, MM</dc:creator>
<dc:creator>Khondkar, P</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Se analizaron extractos crudos y un ácido graso, ácido octadec-7-en-5-ynoic (1), de la corteza de la raíz de Cappariszeylanica Linn. (familia de las Capparidaceae) para observar sus actividades antibacterianas frente a la bacteria Gram positiva y Gram negativa. Entre los extractos crudos, el extracto de cloroformo mostró una buena actividad frente a todos los organismos de prueba. El ácido graso (1) aislado del extracto de cloroformo mostró actividades antibacterianas frente a todos los organismos de prueba, a excepción de E. coli. Las actividades se compararon con un antibiótico estándar: la kanamicina. Las concentraciones inhibitorias mínimas (CIH) de 1, determinadas mediante la técnica de dilución en serie, fueron 64 mg/ml frente a Bacillus subtilis y Shigella dysenteriae. Las actividades citotóxicas del extracto crudo y del ácido graso (1) se observaron mediante el bioensayo de gambas en salmuera yel valor de LC50 del compuesto fue 6,27 mg/ml (AU)</dc:description>
<dc:source>Ars pharm;49(1): 31-37, 2008. ilus, tab</dc:source>
<dc:identifier>ibc-65747</dc:identifier>
<dc:subject>^d6697^s22068</dc:subject>
<dc:subject>^d917^s22078</dc:subject>
<dc:subject>^d6697^s22079</dc:subject>
<dc:subject>^d6697^s22078</dc:subject>
<dc:subject>^d2821^s22067</dc:subject>
<dc:subject>^d28582^s22057</dc:subject>
<dc:subject>^d11379^s29165</dc:subject>
<dc:subject>^d3623</dc:subject>
<dc:subject>^d6697^s22073</dc:subject>
<dc:subject>^d36788^s22021</dc:subject>
<dc:subject>^d6697^s29165</dc:subject>
<dc:subject>^d6697^s22044</dc:subject>
<dc:subject>^d36788^s22046</dc:subject>
<dc:subject>^d36788^s22068</dc:subject>
<dc:subject>^d911^s22078</dc:subject>
<dc:subject>^d911^s22079</dc:subject>
<dc:subject>^d911^s22068</dc:subject>
<dc:type>article</dc:type>
<dc:date>200800</dc:date>
</metadata>
</record>
</ibecs-document>
